FDA Inspection
New York Blood Center EnterprisesNew York Blood Center Enterprises – FDA Inspection, Feb 19, 2026
Record Details
This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on February 19, 2026, issued by the New York District Office, covering biologics.
View Company Profile
ID · 6ae5a8b8-deed-4007-8753-c6c7b04b715d
Inspection Facts
- Inspection number
- 1303442
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 600.12(a)Maintenance - tracing
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.60(a)Provide proper equipment to meet requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center Enterprises
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 1, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 30, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 21, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 8, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 10, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center Enterprises
- FDA Inspection 1145747 - 2021-07-01
- FDA Inspection 1048445 - 2018-03-30
- FDA Inspection 969113 - 2016-04-21
- FDA Inspection 890624 - 2014-08-08
- FDA Inspection 811161 - 2012-12-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.